Drugs for cancer and copayments

Editorial

Ilora Finlay et al. BMJ. 2008.

. 2008 Jun 30;337(7660):a527.

doi: 10.1136/bmj.a527.

Abstract

Principles underpinning copayments must preserve equity, be transparent, and enhance knowledge on treatment outcomes

Competing interests: Nonedeclared.

Critical issue is rapidity of review of new drugs.
Rodger A. Rodger A. BMJ. 2008 Jul 14;337(7662):a779. doi: 10.1136/bmj.a779. BMJ. 2008. PMID: 18625599 Free PMC article. No abstract available.
Why not adopt the blacklist of yore?
Lewis LS. Lewis LS. BMJ. 2008 Jul 14;337(7662):a807. doi: 10.1136/bmj.a807. BMJ. 2008. PMID: 18625603 Free PMC article. No abstract available.
Paradox of complementary medicine.
Doherty J. Doherty J. BMJ. 2008 Jul 22;337:a897. doi: 10.1136/bmj.a897. BMJ. 2008. PMID: 18647778 No abstract available.

1. Commonwealth Fund international health policy survey of adult’s experiences with primary care. New York: Commonwealth Fund, 2004
1. Harris P, Finlay IG, Cook A, Thomas KJ, Hood K. Complementary and alternative medicine use by patients with cancer in Wales: a cross sectional survey. Complement Ther Med 2003;11:249-53. - PubMed